Related Experiment Video
Updated: May 9, 2026

08:26
Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
26.7K
Imaging preclinical tumour models: improving translational power
Marion de Jong1, Jeroen Essers2, Wytske M van Weerden3
1Departments of Nuclear Medicine and Radiology, Erasmus MC Rotterdam, Room Na-610, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.
Nature Reviews. Cancer
|June 20, 2014
Summary
Advanced multimodal imaging and novel probes enhance in vivo cancer research in animal models. These developments support the translation of new cancer therapies from basic research to clinical applications.
Area of Science:
- Biomedical Imaging
- Oncology Research
- Translational Medicine
Background:
- Multimodal imaging techniques for in vivo cancer research have advanced significantly.
- Developments in probe synthesis and labeling offer new tools for basic, translational, and clinical applications.
- Sophisticated cancer models are increasingly available for research.
Purpose of the Study:
- To review recent advancements in multimodal imaging, probe development, and cancer models for in vivo research.
- To highlight the role of imaging in animal cancer models for therapy translation.
- To provide an overview of progress in these three key areas.
Main Methods:
- Review of recent literature on multimodal imaging in animal cancer models.
- Analysis of technological developments in imaging probe synthesis and labeling.
- Examination of advancements in cancer model development for research.
Main Results:
- Multimodal imaging offers enhanced in vivo visualization of cancer processes.
- Novel imaging probes show potential for diverse research and clinical applications.
- Improved cancer models facilitate the study of complex cancer-related questions.
Conclusions:
- Recent progress in imaging, probes, and models significantly enhances cancer research capabilities.
- Imaging in animal models is crucial for translating new cancer therapies to the clinic.
- These integrated developments promise to accelerate cancer treatment advancements.

